Status:
COMPLETED
Greater Occipital and Supraorbital Nerve Blockade in Migraine Patients
Lead Sponsor:
Dr. Lutfi Kirdar Kartal Training and Research Hospital
Conditions:
Migraine Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators aimed to evaluate the efficacy of greater occipital nerve and supraorbital nerve blockade with local anesthetics for the preventive treatment of migraine without aura.
Detailed Description
A mixture of 1 ml 2% lidocaine and 0.9% 1 ml saline was injected bilaterally to GON and SON in the blockade patients. Placebo patients received 2 ml 0.9% saline in the same way. Patients were blinded ...
Eligibility Criteria
Inclusion
- Lack of benefits 1 year from preventive treatment or intolerance to their treatments.
- 18 ≥ years old
- Migraine without aura for more than 1 year, minimum of two or more migraine attacks per month.
Exclusion
- Patients with any chronic illness, medication overuse headache, a history of cranial and cervical surgery
- Allergies to local anesthetics
- Hemorrhagic diathesis
- Alcohol or drug abuse
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
103 Patients enrolled
Trial Details
Trial ID
NCT03435185
Start Date
September 1 2014
End Date
June 1 2016
Last Update
March 23 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.